母体产前接种dTaP-IPV对儿童学龄前加强免疫后脊髓灰质炎免疫应答的影响:一项IV期扩展研究
这项观察性、队列、多中心、开放标签的IV期扩展研究,比较了母亲在孕期接种或未接种含IPV百日咳疫苗的儿童,在学龄前dTaP-IPV加强免疫前后的脊髓灰质炎病毒特异性中和抗体滴度。结果显示,加强免疫前,接种组儿童的抗体几何平均滴度(GMT)显著低于未接种组(4.3 vs 54.7,p=0.0001);加强免疫后,所有儿童均达到保护性抗体水平(≥8),但接种组GMT仍较低(988 vs 2964,p=0.009)。研究表明学龄前加强免疫可弥补基础免疫后的免疫差距,但残余差异需持续监测。
要点
- 产前接种dTaP-IPV的母亲所生儿童,在基础免疫后脊髓灰质炎中和抗体GMT显著低于未接种母亲所生儿童。
- 学龄前dTaP-IPV加强免疫后,所有儿童均达到保护性抗体滴度(≥8),但产前接种组GMT仍显著较低。
- 学龄前加强免疫可克服产前dTaP-IPV接种导致的脊髓灰质炎免疫差距,但残余滴度差异的临床相关性需持续监测。
核心结论
- 学龄前dTaP-IPV加强免疫可使产前接种dTaP-IPV母亲所生儿童达到保护性脊髓灰质炎抗体滴度,克服基础免疫后的免疫差距。
- 加强免疫后,产前接种组儿童的脊髓灰质炎中和抗体GMT仍显著低于未接种组,其临床相关性需继续监测。
研究设计与样本
- 观察性、队列、多中心、开放标签的IV期扩展研究(临床试验注册号NCT03578120)。
- 通过微量中和试验,检测儿童在学龄前dTaP-IPV加强免疫前后的脊髓灰质炎病毒特异性中和抗体滴度。
主要发现
- 学龄前加强免疫前,产前接种dTaP-IPV母亲所生儿童的脊髓灰质炎抗体GMT为4.3,显著低于未接种母亲所生儿童的54.7(p=0.0001)。
- 学龄前加强免疫后,所有儿童无论母亲接种状态均达到保护性抗体滴度(≥8)。
- 加强免疫后,产前接种组儿童的抗体GMT为988,仍显著低于未接种组的2964(p=0.009)。
临床怎么用
- 对于母亲在孕期接种过含IPV百日咳疫苗的儿童,应按程序接种学龄前dTaP-IPV加强疫苗,以确保达到保护性脊髓灰质炎抗体水平。
- 加强免疫后产前接种组抗体滴度仍较低,提示需对这部分儿童群体进行持续免疫监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A diphtheria-tetanus-acellular pertussis-inactivated polio combination vaccine (dTaP-IPV) was offered as part of the UK antenatal vaccination programme from 2012 to July 2024. Prior research established that infants of mothers who received a dTaP-IPV vaccine in pregnancy have significantly reduced poliovirus-specific neutralising antibodies after their primary immunisation series compared with infants of non-dTaP-IPV vaccinated mothers. We investigated whether sufficient poliovirus-specific neutralising antibody titres are achieved in these children following the pre-school dTaP-IPV booster vaccine. Poliovirus-specific neutralising antibody titres were measured, via a microneutralisation assay, prior to and following receipt of the pre-school booster vaccine in blood samples taken during an observational, cohort, multi-centre, open label phase IV extension study. Prior to the pre-school boost, children of mothers who received dTaP-IPV vaccines in pregnancy had lower geometric mean titres (GMT) of antibodies than children of unvaccinated mothers (4.3 vs 54.7, p = 0.0001). However, following administration of the pre-school booster all children, regardless of maternal vaccination status achieved protective antibody titres (≥ 8), although children of vaccinated mothers still had lower GMTs (988 vs 2964, p = 0.009). Administration of the preschool booster overcomes the polio virus immunity gap that develops following the primary vaccination series in children whose mothers received an antenatal dTaP-IPV vaccine versus unvaccinated mothers. Residual differences in post-booster titres warrant continued surveillance to assess their clinical relevance. Clinical trials registry:NCT03578120.
引用
- Radia K, Sapuan S, Grassly N, et al. An observational, cohort, multi-centre, open label phase IV extension study comparing IPV immune responses to preschool dTaP-IPV booster vaccines in children whose mothers received or did not receive an IPV-containing pertussis vaccine during pregnancy in England. Vaccine. 2026. PMID: 41690287. doi:10.1016/j.vaccine.2026.128306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。